Cargando…
Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential Therapy
Triple negative breast cancer (TNBC) is a heterogeneous disease associated with poor clinical outcome and lack of targeted therapy. Here we show that prolactin (PRL) and its signaling pathway serve as a sub-classifier and predictor of pro-differentiation therapy in TNBC. Using immunohistochemistry a...
Autores principales: | López-Ozuna, Vanessa M., Hachim, Ibrahim Y., Hachim, Mahmood Y., Lebrun, Jean-Jacques, Ali, Suhad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969612/ https://www.ncbi.nlm.nih.gov/pubmed/27480353 http://dx.doi.org/10.1038/srep30934 |
Ejemplares similares
-
Concomitant Expression of Prolactin Receptor and TGFβ Receptors in Breast Cancer: Association with Less Aggressive Phenotype and Favorable Patient Outcome
por: Hachim, Ibrahim Y., et al.
Publicado: (2019) -
Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer
por: Tian, Jun, et al.
Publicado: (2017) -
Transforming Growth Factor-beta Regulation of Ephrin Type-A Receptor 4 Signaling in Breast Cancer Cellular Migration
por: Hachim, Ibrahim Y., et al.
Publicado: (2017) -
Author Correction: Transforming Growth Factor-beta Regulation of Ephrin Type-A Receptor 4 Signaling in Breast Cancer Cellular Migration
por: Hachim, Ibrahim Y., et al.
Publicado: (2022) -
Nucleostemin expression in breast cancer is a marker of more aggressive phenotype and unfavorable patients’ outcome: A STROBE-compliant article
por: Sami, Manal M., et al.
Publicado: (2019)